Rotenone Model of Parkinson Disease
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Chronic infusion of rotenone (Rot) to Lewis rats reproduces many features of Parkinson disease. Rot (3 mg/kg/day) was infused subcutaneously to male Lewis rats for 6 days using Alzet minipumps. Control rats received the vehicle only. Presence of 0.1% bovine serum albumin during the isolation procedure completely removed rotenone bound to the mitochondria. Therefore all functional changes observed were aftereffects of rotenone toxicity in vivo. In Rot rat brain mitochondria (Rot-RBM) there was a 30-40% inhibition of respiration in State 3 and State 3U with Complex I (Co-I) substrates and succinate. Rot did not affect the State 4Deltapsi of RBM and rat liver mitochondria (RLM). However, Rot-RBM required two times less Ca2+ to initiate permeability transition (mPT). There was a 2-fold increase in O*2- or H2O2 generation in Rot-RBM oxidizing glutamate. Rot infusion affected RLM little. Our results show that in RBM, the major site of reactive oxygen species generation with glutamate or succinate is Co-I. We also found that Co-II generates substantial amounts of reactive oxygen species that increased 2-fold in the Rot-RBM. Our data suggest that the primary mechanism of the Rot toxic effect on RBM consists in a significant increase of O*2- generation that causes damage to Co-I and Co-II, presumably at the level of 4Fe-4S clusters. Decreased respiratory activity diminishes resistance of RBM to Ca2+ and thus increases probability of mPT and apoptotic cell death. We suggest that the damage to Co-I and Co-II shifts O*2- generation from the CoQ10 sites to more proximal sites, such as flavines, and makes it independent of the RBM functional state.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blockade of rotenone to the binding site of ubiquinone leads to reduced electron flow to complex III and reverse electron flow through complex I into the mitochondrial matrix leading to increased ROS generation in this compartment, namely matrix mtROS [269,416,419,420,421].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [420]
In the citing paper
“ROS can damage TCA-cycle enzymes, especially aconitase and α-ketoglutarate dehydrogenase (62, 168, 249, 250, 277).”
From Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function (2009) · cites this paper as [250]
In the citing paper
“Succinate dehydrogenase (complex II) is very resistant to oxidation by H2O2 or tert-butyl hydroperoxide (tert-BuOOH) (250), but α-ketoglutarate dehydrogenase activity is markedly decreased (168, 250) because of its susceptibility for modification by peroxides of its thiol groups (167, 249).”
From Mitochondrial reactive oxygen species production in excitable cells: Modulators of mitochondrial and cell function (2009) · cites this paper as [250]
Citations
Cites
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Self-citationSuperoxide radical and superoxide dismutases
Fridovich, I. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.000525 · Cited by 3,455
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Mechanism of Toxicity in Rotenone Models of Parkinson's Disease
Sherer, T. B., Betarbet, R., Testa, C. M., Seo, B. B., Richardson, J. R., Kim, J. H., Miller, G. W., Yagi, T., Matsuno-Yagi, A., & Greenamyre, J. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10756.2003 · Cited by 1,072
Self-citationNeurodegenerative diseases and oxidative stress
Emerit, J., Edeas, M., & Bricaire, F. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.11.004 · Cited by 1,031
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines
Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T. (2002) · Nature Neuroscience · doi:10.1038/nn884 · Cited by 1,030
Self-citationCadenas, E., Boveris, A., Ragan, C. I., & Stoppani, A. O. M. (1977) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(77)90035-2 · Cited by 855
Activation of molecular oxygen by flavins and flavoproteins.
Massey, V. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31664-2 · Cited by 816
Classic toxin-induced animal models of Parkinson?s disease: 6-OHDA and MPTP
Schober, A. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0938-y · Cited by 803
Sherer, T. B., Kim, J.-H., Betarbet, R., & Greenamyre, J. T. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 708
Self-citation
Research works printed but not linked: 2
- Cluskey, 2001, Mol. Pathol., 54, 386
- Sherer, 2003, Ann. Neurol., 341, 87
Cited by
Items 201–300 of 311
BmDJ-1 Is a Key Regulator of Oxidative Modification in the Development of the Silkworm, Bombyx mori
Tabunoki, H., Ode, H., Banno, Y., Katsuma, S., Shimada, T., Mita, K., Yamamoto, K., Sato, R., Ishii‐Nozawa, R., & Satoh, J.-I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017683 · Cited by 11
“MPTP, 6-OHDA, PQ, and ROT are used to produce PD models in rats and Drosophila and to analyze the pathology of PD [6,7].”
MethodMitochondrial function influences expression of methamphetamine-induced behavioral sensitization
Calma, I. D., Persons, A. L., & Napier, T. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-04301-9 · Cited by 11
Do mtDNA Mutations Participate in the Pathogenesis of Sporadic Parkinsons Disease?
Kirches, E. (2009) · Current Genomics · doi:10.2174/138920209789503879 · Cited by 11
Novel Drosophila model for parkinsonism by targeting phosphoglycerate kinase
Shimizu, J., Kasai, T., Yoshida, H., Huynh, M. A., Nakao-Azuma, Y., Shinomoto, M., Tokuda, T., Mizuno, T., & Yamaguchi, M. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104816 · Cited by 10
Abdel‐Salam, O. M. E., Khadrawy, Y. A., Youness, E. R., Mohammed, N. A., Abdel-Rahman, R. F., Hussein, J., & Shafee, N. (2013) · Comparative Clinical Pathology · doi:10.1007/s00580-013-1807-4 · Cited by 10
“Oxidative damage might be one mechanism of rotenoneinduced neuronal injury (Sherer et al. 2003b; Panov et al. 2005; Schmidt and Alam 2006).”
BackgroundSun, C., Su, P., Xu, L., Ma, J., & Gu, X. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.239446 · Cited by 10
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Cardoso, S., Santos, R. X., Correia, S. C., Carvalho, C., Zhu, X., Lee, H., Casadesús, G., Smith, M. A., Perry, G. L., & Moreira, P. I. (2009) · Pharmaceuticals · doi:10.3390/ph2030250 · Cited by 10
Temporal Effects of Bisphenol A on Dopaminergic Neurons: An Experiment on Adult Rats
Ishido, M., & Masuo, Y. (2014) · Open Environmental Sciences · doi:10.2174/1876325101408010009 · Cited by 10
“, Cupertino, California, USA) were used as previously described [20].”
MethodBai, Q., He, J., Tang, Y., Wang, S., Qiu, J., Wang, Y., & Yu, C. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3352 · Cited by 10
Vascular Pathology in Male Lewis Rats following Short-Term, Low-Dose Rotenone Administration
Allen, A. L., Luo, C. Y., Montgomery, D. L., Rajput, A. H., Robinson, C. A., & Rajput, A. H. (2009) · Veterinary Pathology · doi:10.1354/vp.08-vp-0114-a-am · Cited by 9
Forced swimming stress does not affect monoamine levels and neurodegeneration in rats
Abbas, G., Naqvi, S., Mehmood, S., Kabir, N., & Dar, A. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1032-6 · Cited by 9
“[30] Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T.”
BackgroundLin, S., Xu, K., Zhang, Q., Zhu, Q., Khan, M. M., Zhang, Z., & Cheng, D. (2022) · Agronomy · doi:10.3390/agronomy12112611 · Cited by 8
Alhadad, M. A., Zaafan, M. A., El-Tanbouly, D. M., El-Brairy, A. I., & Zaki, H. F. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114950 · Cited by 8
Schuh, R. A., Matthews, C. C., & Fishman, P. S. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21772 · Cited by 8
“…where epidemiology (Fleming et al., 1994; LeCouteur et al., 1999; Corrigan et al., 2000; Priyardarshi et al., 2001), animal models (Betarbet et al., 2000; Panov et al., 2005), and autopsy studies (Beal, 1998) implicate both inhibition of the electron transport chain (ETC) and oxidative injury.”
BackgroundYulianti, A. B., Sumarsono, S. H., Ridwan, A., & Yusuf, A. T. (2012) · Journal of Mathematical and Fundamental Sciences · doi:10.5614/itbj.sci.2012.44.4.3 · Cited by 8
Dietary Phytochemicals in Neurodegenerative Disease
Jacquet, A. D. R., Tambe, M. A., & Rochet, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00018-7 · Cited by 8
Seneff, S., Nigh, G., & Kyriakopoulos, A. M. (2025) · Biocell · doi:10.32604/biocell.2025.066687 · Cited by 7
Ye, Z., Hou, H., Zhang, G., Li, H., Chen, T.-F., Gao, Y.-H., Song, L., & Zhang, Z. (2020) · World Journal of Traditional Chinese Medicine · doi:10.4103/wjtcm.wjtcm_72_20 · Cited by 7
Dutta, A., Phukan, B. C., Roy, R., Mazumder, M. K., Paul, R. K., Choudhury, A., Kumar, D., Bhattacharya, P., Nath, J., Kumar, S., et al. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01001-9 · Cited by 7
The role of mitochondria-targeted antioxidant MitoQ in neurodegenerative disease
Zhang, L., Reyes, A., & Wang, X. (2018) · Journal of Green Engineering · doi:10.26781/2052-8426-2018-01 · Cited by 8
Manganese in atherogenesis: Detection, origin, and a role
Lozhkin, A. P., Biktagirov, T., Abdul’yanov, V. A., Gorshkov, O. V., Timonina, E. V., Mamin, G. V., Orlinskiĭ, S. B., Silkin, N. I., Chernov, V. M., Хайруллин, Р. Н., et al. (2011) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750811020090 · Cited by 7
Manganese in atherogenesis: detection, origin, and role
Lozhkin, A. P., Biktagirov, T., Gorshkiv, O. V., Timonina, E. V., Mamin, G. V., Orlinskiĭ, S. B., Silkin, N. I., Chernov, V. M., Хайруллин, Р. Н., Салахов, М. Х., et al. (2012) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20125803291 · Cited by 7
Toxin-Mediated Complex I Inhibition and Parkinson’s Disease
Miranda, B. R. D., Houten, B. V., & Sanders, L. H. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_6 · Cited by 7
Beneficial effects of phenolic compounds from fruit and vegetables in neurodegenerative diseases
Singh, M., & Ramassamy, C. (2008) · Elsevier eBooks · doi:10.1533/9781845694289.2.145 · Cited by 7
Darbinyan, L., Սիմոնյան, Կ. Վ., Hambardzumyan, L. E., Simonyan, M. A., Simonyan, R. M., & Manukyan, L. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01237-z · Cited by 6
García-Aguilar, R., Ortega, A., López‐Bayghen, E., Ramírez-Martínez, L., Rodríguez-Campuzano, A. G., Murillo-González, F. E., Elizondo, G., & Vega, L. (2023) · NeuroToxicology · doi:10.1016/j.neuro.2023.11.007 · Cited by 6
Mitochondria, Sodium, and Calcium in Neuronal Dysfunction
Nicholls, D. G. (2011) · Springer eBooks · doi:10.1007/978-0-85729-701-3_7 · Cited by 6
Luisetto, M., AL-Mukhtar, N. J., Rafa, A. Y., Nili-Ahmadabadi, B., Mashori, G. R., Khan, F. A., Sahu, R. K., Hamid, G. A., & Edbey, K. (2019) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001019 · Cited by 6
Lev, N., Melamed, E., & Offen, D. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)84050-4 · Cited by 6
“Activated microglia upregulate cell surface markers such as the macrophage antigen complex I and produce a variety of proinflammatory cytokines, leading to ROS production.”
BackgroundInfluentialAnimal Models of Parkinson's Disease to Aid Drug Discovery and Development
Merchant, K., Chesselet, M.-F., Hu, S., & Fahn, S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00017-5 · Cited by 6
Qiao, Y., Kou, J., Tian, Y., Ma, W., Yu, Y., Pang, J., Pei, Y., Zhang, Y., Ye, B., Xie, Z., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107773 · Cited by 5
“These toxins affecting mitochondria cause defects in the activity of the mitochondrial electron transport complex (7), reduce movement of mitochondria (8), cause an increase in the mitochondrial permeability transition, increase the generation of reactive oxygen species, and damage the activity of…”
BackgroundBusanello, E. N. B., Marques, A. C. S., Lorza‐Gil, E., Oliveira, H. C. F., & Vercesi, A. E. (2018) · InTech eBooks · doi:10.5772/intechopen.71610 · Cited by 5
“[145] Panov A, Dikalov S, Shalbuyeva N, Taylor G, Sherer T, Greenamyre JT.”
BackgroundSantos, E. W., Khatoon, S., Zheng, Y., & Wang, Y.-X. (2025) · Cells · doi:10.3390/cells14161260 · Cited by 5
Fluorescence-Based Imaging Techniques
Khelfi, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-60738-7_11 · Cited by 4
High Mobility Group Box 1 Protein: A Plausible Therapeutic Molecular Target in Parkinson’s Disease
Goyal, A., Agrawal, A., Dubey, N., & Verma, A. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201025666230905092218 · Cited by 4
Lycas, M. D., Morado, D. R., Gether, U., Briggs, J. A. G., & Erlendsson, S. (2026) · The Journal of Cell Biology · doi:10.1083/jcb.202503059 · Cited by 4
Animal models of Parkinson’s disease and related disorders
Petzinger, G. M., & Jakowec, M. W. (2013) · CRC Press eBooks · doi:10.1201/b14361-17 · Cited by 4
Rahman, M. M., Sarker, M. T., Ahmed, S., Uddin, M. N., Islam, M. S., Islam, M. R., Das, S., Mukherjee, N., Hemeg, H. A., Rauf, A., et al. (2023) · Process Biochemistry · doi:10.1016/j.procbio.2023.07.007 · Cited by 4
Manouchehri, N., Khodagholi, F., Dargahi, L., & Ahmadiani, A. (2019) · PubMed Central · doi:10.22037/ijpr.2019.1100711 · Cited by 4
Nieminen, A., Ramshesh, V. K., & Lemasters, J. J. (2008) · Wiley eBooks · doi:10.1002/9780470372531.ch17 · Cited by 4
Chronic Administration with Rotenone does not Enhance MPTP Neurotoxicity in C57BL/6 Mice
Aoki, E., Yokoyama, H., Kimoto, H., Yano, R., Kato, H., & Araki, T. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9220-9 · Cited by 4
Major histocompatibility complex expression in a rotenone model of Parkinson’s disease in rats
Ishido, M., & Shimaya, E. (2016) · Fundamental Toxicological Sciences · doi:10.2131/fts.3.101 · Cited by 4
“Rotenone is derived from plants and commonly used as a pesticide (Ray, 1991), and chronic rotenone exposure reproduces a number of features of Parkinson’s disease, including nigrostriatal dopaminergic lesions (Panov et al., 2005; Inden et al., 2007).”
BackgroundMethodShtanova, L. Y., Yanchuk, P. I., & Veselsky, S. P. (2020) · The Ukrainian Biochemical Journal · doi:10.15407/ubj92.06.085 · Cited by 4
“Inhibition of mitochondrial complex I causes impaired respiration and energy deficiency in the cell [25].”
BackgroundGenes involved in the development of Parkinson
Teixeira, D., & Cardoso, I. (2017) · Open Journal of Parkinson s Disease and Treatment · doi:10.17352/ojpdt.000005 · Cited by 3
Metabolic dysfunctions in the intranigral rotenone model of Parkinson’s disease
Chuproski, A. P., de Azevedo, E. M., Ilkiw, J. L., Miloch, J., & Lima, M. M. S. (2023) · Experimental Brain Research · doi:10.1007/s00221-023-06605-w · Cited by 3
Abdel-Rahman, M., Ahmed, H. H., & Moniem, A. E. A. (2008) · Cited by 3
The obtaining of toxic chronic model of parkinsonism syndrome in rats
Aleinikava, N. Y., Boika, A. V., Nizheharodava, D. B., Пономарев, В. В., Vanslau, M. I., Ustsiamchuk, A. M., Ihnatovich, T. V., Kuznetsova, T. Y., Гладкова, Ж. А., & Zafranskaya, M. M. (2018) · Vestnik of Vitebsk State Medical University · doi:10.22263/2312-4156.2018.6.92 · Cited by 3
Oxyresveratrol: A Potential Pharmacological Prospective Against Neurodegenerative Diseases
Mahamud, N., Suksuwan, A., Waloh, N., Salae, K., Tansawat, R., & Dahlan, W. (2023) · Journal of Natural Remedies · doi:10.18311/jnr/2023/31334 · Cited by 2
Dubinin, M. V., Ilzorkina, A. I., Salimova, E. V., Landage, M. S., Khoroshavina, E. I., Gudkov, S. V., Belosludtsev, K. N., & Parfenova, L. V. (2023) · Membranes · doi:10.3390/membranes13100835 · Cited by 2
“H 2 O 2 production by mitochondria was monitored using an Amplex Red assay ( λ ex = 560 nm; λ em = 590 nm) and a Varioskan LUX plate spectrofluorometer (Thermo Fisher Scientific, Waltham, MA, USA) at 37 ◦ C [31].”
MethodMitochondrial Fission-Fusion and Parkinson’s Disease: A Dynamic Question of Compensatory Networks
Chu, C. T., & Berman, S. (2011) · Springer eBooks · doi:10.1007/978-94-007-1291-1_7 · Cited by 2
“the active metabolite of the heroin contaminant MPTP (Przedborski et al. 2004; Panov et al. 2005).”
BackgroundDickey, A. S., & Spada, A. R. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_12 · Cited by 2
“These mitochondrial toxins inhibit the mitochondrial electron transport complex activity [ 6 ], increase the mitochondrial permeability transition, reduce mitochondrial movement [ 7 ], and increase mitochondrial nitric oxide synthase (NOS) activity, suggesting involvement of mitochondrial complexI in PD pathogenesis.”
BackgroundThe temporal turning window for rat behavioral phenotypes by rotenone
Ishido, M. (2018) · Fundamental Toxicological Sciences · doi:10.2131/fts.5.195 · Cited by 2
Models of oxidative stress in the biology of aging
Lithgow, G. J., & Andersen, J. K. (2005) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2005.11.009 · Cited by 2
Bonvallot, N., Brimo, S., Boudes, P., Coumoul, X., Duboc, S., Mougin, C., & Salles, B. (2021) · HAL · doi:10.17180/zfqx-ea34 · Cited by 2
Wojciechowska, O., Jourdes, M., Andrusiewicz, M., Pokrzywa, M., Karaźniewicz‐Łada, M., Jodynis-Liebert, J., Teissèdre, P., & Kujawska, M. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102263 · Cited by 1
Lead Phytomolecules for Treating Parkinson’s Disease
Agrawal, K. K., Veer, C., Murti, Y., & Singh, S. P. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249355503241210101001 · Cited by 1
Kuznetsova, E. A., & Sirota, N. P. (2024) · BIOPHYSICS · doi:10.1134/s000635092470074x · Cited by 1
Ismael, S., Baitamouni, S., & Lee, D. (2025) · NeuroSci · doi:10.3390/neurosci6010024 · Cited by 1
Cellular and Molecular Mechanisms Contributing to Parkinson’s Disease
Madhuranthagan, M., Benito Johnson., D., Essly Selva Jasmine., P., Suresh., R., & Senthil Kumar., C. (2026) · Research Journal of Pharmacology and Pharmacodynamics · doi:10.52711/2321-5836.2026.00005 · Cited by 1
A longitudinal study of rotenone-induced Parkinsonism in mice
Joshi, P., Fan, F., & Lou, X. (2026) · iScience · doi:10.1016/j.isci.2026.117996 · Cited by 1
Dunn, D. A., Irwin, M. H., Moos, W. H., Steliou, K., & Pinkert, C. A. (2018) · Wiley eBooks · doi:10.1002/9781119329725.ch19 · Cited by 1
Darbinyan, L., Hambardzumyan, L. E., Simonyan, K. V., Chavushyan, V. A., Manukyan, L., Badalyan, S. A., & Sarkisian, V. H. (2016) · Morphologia · doi:10.26641/1997-9665.2016.4.29-34 · Cited by 1
Role of Mitochondria and Oxidative Stress in Parkinson’s Disease
Santos, R. X., Correia, S. C., Cardoso, S., Carvalho, C., Candeias, E., Plácido, A. I., Duarte, A. I., Santos, M. S., & Moreira, P. I. (2014) · CRC Press eBooks · doi:10.1201/b16653-26 · Cited by 1
Kuznetsova, E. A., & Sirota, N. P. (2024) · Биофизика · doi:10.31857/s0006302924040094 · Cited by 1
ESTUDO DO EFEITO NEUROPROTETOR DA DULOXETINA
Engel, D. F. (2013) · Americanae (AECID Library) · Cited by 1
Estudo farmacogenético da acção do propofol no sistema energético mitocondrial em células hela
Lapa, T. A. S. C. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
The Effects of Oxidative Stress on Calcineurin Activity and DJ-1 Subcellular Localization
Diec, D. (2009) · TSpace (University of Toronto) · Cited by 1
Moloney, K. (2011) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2011-07061 · Cited by 1
Pointon, A. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Issa, S. A.-R. (2015) · theses.fr (ABES) · doi:10.70675/bac47709za653z4723z85f6z620ca3c186e3 · Cited by 1
The role of telomerase in brain during ageing and under dietary restriction
Czapiewski, R. (2013) · Cited by 1
Structural and Metabolic Determinants of Mitochondrial Superoxide and its Detection Methods
Panov, A. V., & Dikalov, S. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_6
Self-citationMolecular and Cellular Characterization of Dopamine Neuron Stimulating Peptides
Kelps, K. A. (2013) · UKnowledge (University of Kentucky)
de Pedro, N. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Rojas-Martinez, J. C. (2009) · Texas ScholarWorks (Texas Digital Library)
Peroxynitrite and Mitochondrial Cytochromes
Manzano, E. L. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Understanding the Role of Sirtuin 3 in a Cell Model of Parkinson's Disease
Lizal, K. E. (2013) · TSpace (University of Toronto)
Study of Free-Radical Processes during Rotenone Modeling of Parkinson Disease
Ghazaryan, N. A., Ghulikyan, L. A., Chavushyan, V. A., & Ayvazyan, N. M. (2016) · Journal of Biophysical Chemistry · doi:10.4236/jbpc.2016.71001
Genes envolvidos na determinação de Parkinson
Teixeira, D. D. C. E. C. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Investigating novel therapeutic approaches and targets to prevent synapse degeneration
Amorim, I. D. S. (2017) · ERA
Imaging Mitochondrial Membrane Potential and Inner Membrane Permeability
Nieminen, A., Ramshesh, V. K., & Lemasters, J. J. (2018) · Wiley eBooks · doi:10.1002/9781119329725.ch28
Reich, V. (2016) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-5942
The role of Galectin-3 in the pathogenesis of Parkinson's Disease
Revilla, J. G. (2019) · Deposito de Investigacion Universidad de Sevilla (University of Seville)
PARKINSONISM SYNDROME FORMATION IN EXPERIMENTAL ANIMALS. NEUROINFLAMMATORY PENUMBRA
Boika, A. V., Aleinikava, N. Y., Пономарев, В. В., Ustsiamchuk, A. M., & Ivanchik, H. I. (2021) · Vestnik of Vitebsk State Medical University · doi:10.22263/2312-4156.2021.4.53
Ippolito, A. N., Atwater, B. L., DiFelice, L. A., & Digioia, A. M. (2013) · Digital WPI
Poghosyan, М. V., Hovsepyan, M., Danielyan, M., Hambardzumyan, L. E., Манукян, Л. П., & Sarkissian, J. S. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022010021
Animal models of Parkinson’s disease and related disorders
Petzinger, G. M., & Jakowec, M. W. (2013) · Informa Healthcare eBooks · doi:10.3109/9781841849096.014
Costa, J. V. C. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2022.tde-07112023-151721
Cacoa Prevents Degeneration of Dopamine Neurons and Motor Impairment Caused by Rotenone
El-Shamarka, M. E.-S., Abdel‐Salam, O. M. E., & Shaffie, N. (2025) · International Journal of Applied Sciences & Development · doi:10.37394/232029.2025.4.11
Kabartan, E., Yavuz, B. T., Şirin, C., Hacıoğlu, G., & Cırrık, S. (2025) · Ege Tıp Dergisi · doi:10.19161/etd.1762616
Aconitasa mitocondrial: impacto metabólico de la inactivación por especies oxidantes
Scandroglio Outmazían, F. K. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Zuluaga Vélez, A. (2015) · Americanae (AECID Library)
Analyzing the function of TRAP1 in models of Parkinson’s disease
Zhang, L. (2016) · RWTH Publications (RWTH Aachen)
Metadata
- Authors
- Panov, A., Dikalov, S., Shalbuyeva, N., Taylor, G., Sherer, T., & Greenamyre, J. T.
- Affiliations
- Carolinas Healthcare System (US)
- Emory University (US)
- Corresponding author
- Panov, Alexander
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 280
- Issue
- 51
- Pages
- 42026-42035
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1996971085
- Cited by
- 288
- References
- 54
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 10 · 2023: 11 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 14 · 2017: 16 · 2016: 15 · 2015: 8 · 2014: 19 · 2013: 24 · 2012: 15
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5419 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (ES012068, U54ES012068)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- rotenone, Parkinson's disease, mitochondrial complex I, complex II, reactive oxygen species, superoxide production, mitochondrial permeability transition, mitochondrial respiration, glutamate oxidation, succinate oxidation, [4Fe-4S] cluster, apoptosis, Lewis rats
- MeSH terms
- Animals, Brain, Disease Models, Animal, Male, Mitochondria, Parkinson Disease, Rats, Inbred Lew, Rotenone, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.